New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 16, 2014
09:06 EDTINSVInSite Vision momentum turning positive, says Roth Capital
Roth Capital believes that recent events, including a patent that InSite received for BromSite and the company's collaboration with Senju Pharmaceutical in Japan, are positive and set the stage for larger business development deals. The firm keeps a Buy rating on the stock for speculative investors.
News For INSV From The Last 14 Days
Check below for free stories on INSV the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for INSV

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use